OSSIO is an orthopedic company providing an innovative alternative to metal implants in the more than $10 billion orthopedic fixation market with its intelligent bone implant technology.
OSSIOfiber is a biofriendly implant material that is stronger than cortical bone and leaves nothing permanent behind. Stemming from years of biomechanical research and a vision for the possibility of better bone healing, OSSIOfiber is engineered to provide the strength required for functional fixation and allows for full integration into the native anatomy without adverse inflammation.
OSSIOs proprietary technology can address many surgical applications through the manufacture of endless implant designs. In addition, OSSIOfiber implants utilize existing reimbursement and surgical techniques.
Cumulative Funding Raised Over Time ($)
Employees Over Time
OSSIO Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Dec 2, 2024
www.businesswire.com
OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues
null
Oct 18, 2022
www.finsmes.com
Ossio Closes $38.5M Series C Financing
#Investment
Aug 8, 2022
www.businesswire.com
OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
undefined
Mar 29, 2022
www.businesswire.com
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
#Customers, Expand
Mar 3, 2022
www.odtmag.com
OSSIO Wins GPO Contract for Bio-Integrative Fixation Tech
OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues
null
Oct 18, 2022
www.finsmes.com
Ossio Closes $38.5M Series C Financing
#Investment
Aug 8, 2022
www.businesswire.com
OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
undefined
Mar 29, 2022
www.businesswire.com
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
#Customers, Expand
Mar 3, 2022
www.odtmag.com
OSSIO Wins GPO Contract for Bio-Integrative Fixation Tech